These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Experience with leptril therapy for preschool children]. Semenovskaia EI; Rozengauz RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1579-82. PubMed ID: 4149525 [No Abstract] [Full Text] [Related]
46. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers. Molcan J; Floreánová L; Polák L Act Nerv Super (Praha); 1972; 14(2):97. PubMed ID: 5040183 [No Abstract] [Full Text] [Related]
47. [Somatic disorders during long-term drug treatment of schizophrenic patients]. vom Brocke I Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663 [No Abstract] [Full Text] [Related]
48. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)]. Bruck J; Guss H Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320 [No Abstract] [Full Text] [Related]
49. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment]. Koga M Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910 [TBL] [Abstract][Full Text] [Related]
50. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Correll CU; Penzner JB; Parikh UH; Mughal T; Javed T; Carbon M; Malhotra AK Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):177-206. PubMed ID: 16321730 [TBL] [Abstract][Full Text] [Related]
51. Are there any news about the antipsychotic medications in the elderly? Cucinotta D; Minardi M; Lanfranchi G; Reggiani A; Savorani G Arch Gerontol Geriatr; 2007; 44 Suppl 1():133-7. PubMed ID: 17317446 [TBL] [Abstract][Full Text] [Related]
52. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C; Vaksdal K Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]
53. Thiothixene and the thioxanthenes. Ban TA; Lehmann HE Adv Biochem Psychopharmacol; 1974; 9(0):481-6. PubMed ID: 4836220 [No Abstract] [Full Text] [Related]
54. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825 [TBL] [Abstract][Full Text] [Related]
55. [Additional possibilities for correction of movement disorders induced by neuroleptics in patients with schizophrenia]. Semenikhin DG; Kuchaeva AV; Karpov AM; Mikhaĭlova EB; Murav'eva AV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):78-80. PubMed ID: 24429952 [No Abstract] [Full Text] [Related]
56. The problem of tardive akathisia. Gualtieri CT Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819 [TBL] [Abstract][Full Text] [Related]
57. [Tolerance of bromperidol in long term application]. Scelovic B Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477 [No Abstract] [Full Text] [Related]
58. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses. McConville BJ; Sorter MT J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523 [TBL] [Abstract][Full Text] [Related]